These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21492416)

  • 1. Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol.
    Chang AB; Grimwood K; White AV; Maclennan C; Sloots TP; Sive A; McCallum GB; Mackay IM; Morris PS
    Trials; 2011 Apr; 12():94. PubMed ID: 21492416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB
    BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial.
    McCallum GB; Morris PS; Chatfield MD; Maclennan C; White AV; Sloots TP; Mackay IM; Chang AB
    PLoS One; 2013; 8(9):e74316. PubMed ID: 24086334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.
    McCallum GB; Morris PS; Grimwood K; Maclennan C; White AV; Chatfield MD; Sloots TP; Mackay IM; Smith-Vaughan H; McKay CC; Versteegh LA; Jacobsen N; Mobberley C; Byrnes CA; Chang AB
    Front Pediatr; 2015; 3():32. PubMed ID: 25954737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile phones support adherence and retention of indigenous participants in a randomised controlled trial: strategies and lessons learnt.
    McCallum GB; Versteegh LA; Morris PS; Mckay CC; Jacobsen NJ; White AV; D'Antoine HA; Chang AB
    BMC Public Health; 2014 Jun; 14():622. PubMed ID: 24943961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial.
    Pinto LA; Pitrez PM; Luisi F; de Mello PP; Gerhardt M; Ferlini R; Barbosa DC; Daros I; Jones MH; Stein RT; Marostica PJ
    J Pediatr; 2012 Dec; 161(6):1104-8. PubMed ID: 22748516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
    Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K
    BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for bronchiolitis in children under two years of age.
    Farley R; Spurling GK; Eriksson L; Del Mar CB
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005189. PubMed ID: 25300167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial).
    Pavlinac PB; Singa BO; John-Stewart GC; Richardson BA; Brander RL; McGrath CJ; Tickell KD; Amondi M; Rwigi D; Babigumira JB; Kariuki S; Nduati R; Walson JL
    BMJ Open; 2017 Dec; 7(12):e019170. PubMed ID: 29289941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
    Beigelman A; Goss CW; Wang J; Srinivasan M; Boomer J; Zhou Y; Bram S; Casper TJ; Coverstone AM; Kanchongkittiphon W; Kuklinski C; Storch GA; Schechtman KB; Castro M; Bacharier LB
    Ann Allergy Asthma Immunol; 2024 May; 132(5):623-629. PubMed ID: 38237675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of severity and readmission of Indigenous and non-Indigenous children hospitalised for bronchiolitis.
    Bailey EJ; Maclennan C; Morris PS; Kruske SG; Brown N; Chang AB
    J Paediatr Child Health; 2009 Oct; 45(10):593-7. PubMed ID: 19751375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS
    Trials; 2013 Feb; 14():53. PubMed ID: 23421781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.
    Wainwright C; Altamirano L; Cheney M; Cheney J; Barber S; Price D; Moloney S; Kimberley A; Woolfield N; Cadzow S; Fiumara F; Wilson P; Mego S; VandeVelde D; Sanders S; O'Rourke P; Francis P
    N Engl J Med; 2003 Jul; 349(1):27-35. PubMed ID: 12840089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol.
    ABCD study team
    Trials; 2020 Jan; 21(1):71. PubMed ID: 31931848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
    Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.